Acute and long-term treatment of depression and schizophrenia: A survey on the observance of the international guidelines for relapse prevention;UNSER WISSEN IST STUCKWERK. EINE UMFRAGE UBER DIE EINHALTUNG INTERNATIONALER RICHTLINIEN BEZUGLICHE AKUTER UND DAUERTHERAPIE BEI REZIDIVIERENDEN DEPRESSIONEN UND BEI ERKRANKUNGEN AUS DEM SCHIZOPHRENEN FORMENKREIS

Praxis

Volumn 85, Issue 24, 1996, Pages 792-797

  Ramseier, F ^a  

^a Psychiat Dienste des Kantons Aargau   (Switzerland)

Author keywords

antidepressants; compliance of physician; continuation therapy; neuroleptics; relapse prevention

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

ARTICLE; DEPRESSION; DRUG THERAPY; GENERAL PRACTITIONER; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PREVENTION; PSYCHIATRIST; QUESTIONNAIRE; RECURRENT DISEASE; SCHIZOPHRENIA; COMPARATIVE STUDY; GENERAL PRACTICE; PSYCHIATRY; WORLD HEALTH ORGANIZATION;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSION; FAMILY PRACTICE; HUMANS; PRACTICE GUIDELINES; PSYCHIATRY; RECURRENCE; SCHIZOPHRENIA; WORLD HEALTH ORGANIZATION;

EID: 0030579806     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Burrows G. D.: Long Term Clinical Management of Depressive Disorders. J. Clin. Psychiatry 53 (Suppl. 3), 32-35, 1992.
2. Davis John M. et al.: Dose Response of Prophylactic Antipsychotics. J. Clin. Psychiatry 54 (Suppl. 3), 24-30, 1993.
3. Frank E. et al.: Three-Year Outcomes of Maintenance Therapies in Recurrent Depression. Arch. Gen. Psychiatry 47, 1093-1099, 1990.
4. Frank E. et al.: Comparison of Full-Dose Versus Half-Dose in the Maintenance Treatment of Recurrent Depression. J. Affec. Dis. 27, 139-145, 1993.
5. Johnson D. A. W. et al.: Double Blind Comparison of Half-Dose and Standard Dose Flupenthixol Decanoate in the Maintenance Treatment of Stabilised out Patient with Schizophrenia. Br. J. Psychiatry 151, 634-638, 1987.
6. Johnstone E. C.: Schizophrenia - Problem in Clinical Practice. Lancet 341, 536-538, 1993.
7. Kissling W.: Guidelines for Neuroleptic Relapse Prevention in Schizophrenia. Springer Verlag, Berlin, 1991.
8. Kissling W.: Ideal and Reality of Neuroleptic Relapse Prevention. Br. J. Psychiatry 161 (Suppl. 18), 133-139, 1992.
9. Keller M. B.: The Difficult Depressed Patient in Perspective. J. Clin. Psychiatry 54 (Suppl. 2), 4-8, 1993.
10. Küchenhoff B., Hell D.: Die Schizophrenie-behandlung in der ärztlichen Praxis. Schweiz. Rundschau Med. (PRAXIS) 82, 510-515, 1993,
11. Kupfer D. J. et al.: Five-Year Outcome for Maintenance Therapies in Recurrent Depression. Arch. Gen. Psychiatry 49, 769-773, 1992.
12. Kupfer D. J.: Management of Recurrent Depression. J. Clin. Psychiatry 54 (Suppl. 2), 29-33, 1993.
13. Marder S. R.: Low and Conventional Dose Maintenance Therapy with Fluphenazive Decanoate. Arch. Gen. Psychiatry 44, 518-521, 1987.
14. Paykel E. S., Priest R. G.: Recognition and Management of Depression in General Practice - Consensus Statement. Br. Med. J. 305, 1198-1202, 1992.
15. Pietzcker A. et al.: Intermittent Versus Maintenance Neuroleptic Long Term Treatment in Schizophrenia - 2 Year Results of a German Multicenter Study. J. Psychiat. Res. 27, 321-339, 1994.
16. Rouillon F. et al.: Rechutes de dépression unipolaire et efficacité de la maprotiline. Encéphale 15, 527-534, 1989.
17. Thase M. E.: Long-Term Treatments of Recurrent Depressive Disorders. J. Clin. Psychiatry 53 (Suppl. 9), 32-44, 1992.
18. Thase M. E.: Maintenance Treatments of Recurrent Affective Disorders. Cur. Opin. Psychiatry 6, 16-21, 1993.
19. WHO Mental Health Collaborating Centres: Pharmacotherapy of Depressive Disorders. J. Aff. Dis. 17, 197-198, 1989.
20. American Psychiatric Association: Practice Guideline for Major Depressive Disorder in Adults. Am. J. Psychiatry 150, 4, Suppl., 1993.